Estudos clínicos com novas drogas em ELA

      

Nome	Tipo	Pac	Fase	Local	Inicio	Fim
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) (Tirasemtiv)	Intervencionista	680	IIb	EUA	10/12	03/14
Masitinib em ensaio de Fase III para o tratamento da ELA ( Kinavet-EUA) OBS: não foi encontrado no clinicaltrials	Intervencionista	210	III	Argentina	2014	2015
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) (MX-ALS-001) (Mexitil)	Intervencionista	60	II	EUA	07/13	06/14
Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis	Intervencionista	294	?	Div paises	12/12	05/15
Gilenya in Amyotrophic Lateral Sclerosis  (ALS) (Fingolimod)	Intervencionista	30	IIa	EUA	08/13	06/14
Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis	Intervencionista	80	II/III	EUA	01/09	12/16
Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)	Intervencionista	136	II	EUA	02/11	09/12
A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis	Intervencionista	18	I/II	Belgica	12/08	06/11
Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations (SOD-1)	Intervencionista	33	I	EUA	01/10	01/12

Fonte:
 ClinicalTrials.gov
http://www.researchals.org/page/4832/12345/ https://br-mg4.mail.yahoo.com/neo/launch?.rand=7u1rrrikk80pv#mail  http://www.mndassociation.org/research/MND+research+and+you/treatments-trials    http://www.falandosobreela.blogspot.com.br/2012/11/pesquisas-e-ensaios-clinicos-em-ela.html